ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.77 -0.0233 (-2.94%) Market Cap: 21.02 Mil Enterprise Value: 29.23 Mil PE Ratio: 0 PB Ratio: 0.84 GF Score: 53/100

Q3 2023 Immunoprecise Antibodies Ltd Earnings Call Transcript

Mar 16, 2023 / 02:30PM GMT
Release Date Price: $3.37 (-10.13%)
Operator

Good morning, and welcome to IPA's earnings call for the third-quarter fiscal year 2023. I am Regina, and I will be your host for today's call.

Before we begin, I would like to remind everyone that our remarks today may include forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in our statements. We encourage you to review our filings with the Securities and Exchange Commission for a more complete discussion of these risks and uncertainties. IPA undertakes no obligation to update these forward-looking statements, except as required by law.

On today's conference call and the accompanying presentation slides, non-GAAP financial measures will be used to help investors and analysts understand IPA's business performance. IPA believes adjusted EBITDA reflects the business in a manner that allows for a meaningful period-to-period comparisons and analysis of trends in its business. An explanation and reconciliation of non-GAAP to GAAP measures can be found in the text of our management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot